Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/27/2012CA2829598A1 Methods for improving bone health in infants using prebiotics
09/27/2012CA2829466A1 Benzo [b] [1,4] oxazin derivatives as calcium sensing receptor modulators
09/27/2012CA2829263A1 A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof
09/27/2012CA2829107A1 A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide
09/27/2012CA2829050A1 A 5-ht4 receptor agonist as a prokinetic agent
09/27/2012CA2827969A1 Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators
09/27/2012CA2825966A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012CA2822783A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/27/2012CA2805805A1 Bendamustine anionic-catioinic cyclopolysaccharide compositions
09/26/2012EP2503005A2 Cortexolone-17alpha-propionate in cristalline hydrate form IV
09/26/2012EP2503004A1 Cortexolone-17alpha-propionate in crystalline form I
09/26/2012EP2502999A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
09/26/2012EP2502997A1 MicroRNA inhibiting nucleic acid molecule
09/26/2012EP2502925A1 Pyridine imidazoles and aza-indoles as progesterone receptor modulators
09/26/2012EP2502924A1 Novel pyrimidine derivatives
09/26/2012EP2502921A1 Arylsulfonamide CCR3 antagonists
09/26/2012EP2502918A1 Pyridizinone Derivatives
09/26/2012EP2502917A1 Solid state crystalline forms of 4-(2-ethyl-5-fluoro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole
09/26/2012EP2502916A1 Organic dicarboxylic acids, salts and preparation method thereof
09/26/2012EP2502914A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2502912A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2502911A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2502910A1 Camphorsulfonic salt of a key Montelukast intermediate
09/26/2012EP2502909A1 Aminopyridine derivative
09/26/2012EP2502907A1 Substituted 4-aminocyclohexane derivatives
09/26/2012EP2502906A2 Trypsin-like serine protease inhibitors, their preparation and use
09/26/2012EP2502649A1 Combination therapy using HDAC inhibitors and erlotinib for treating cancer
09/26/2012EP2502635A1 Combined formulations for the treatment of male infertility
09/26/2012EP2502628A2 Polynucleotides and polypeptide sequences involved in cancer
09/26/2012EP2502627A1 Anti-cancer agent
09/26/2012EP2502626A1 Crystalline levofolinic acid and process for its preparation
09/26/2012EP2502625A1 Process for the preparation of crystalline levofolinic acid
09/26/2012EP2502624A1 Lonidamine analogues and their use in male contraception and cancer treatment
09/26/2012EP2502623A1 Promoting Axon Regeneration in the Adult CNS through Control of Protein Translation
09/26/2012EP2502620A1 Solid pharmaceutical composition comprising donepezil
09/26/2012EP2502619A2 Systems and methods for delivery of materials
09/26/2012EP2502616A1 Pharmaceutical nasal composition
09/26/2012EP2502507A1 Methods for improving bone health in infants using prebiotics
09/26/2012EP2502506A1 Methods for improving bone health in infants using long chain polyunsaturated fatty acids
09/26/2012EP2502077A1 Predictive markers for taxane responsiveness and methods of use thereof
09/26/2012EP2502068A2 Urinary triaosylceramide (gb3) as a marker of cardiac disease
09/26/2012EP2501761A2 Use of physiological cooling active ingredients, and agents containing such active ingredients
09/26/2012EP2501754A1 Novel formulation of physiological chitosan-inorganic salt solution/blood mixtures for tissue repair
09/26/2012EP2501709A2 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections
09/26/2012EP2501706A1 A novel 3-substituted 7-imino-2-thioxo-3, 7-dihydro-2h-thiazolo [4,5-di pyrimidin-6-yl - and process for preparation thereof
09/26/2012EP2501705A1 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
09/26/2012EP2501704A1 Spiropiperidine compounds as orl-1 receptor antagonists
09/26/2012EP2501703A1 Spiropiperidine compounds as orl-1 receptor antagonists
09/26/2012EP2501700A1 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof
09/26/2012EP2501699A1 New macrocyclic derivatives of glycolurils, and methods of preparing and using the same
09/26/2012EP2501697A1 Benzoimidazole compounds and uses thereof
09/26/2012EP2501695A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
09/26/2012EP2501694A1 Process for the preparation of crystalline form ii of l-malic acid salt of sunitinib
09/26/2012EP2501693A1 Novel heterocyclic acrylamides and their use as pharmaceuticals
09/26/2012EP2501691A1 Substituted pyrrolidine-2-carboxamides
09/26/2012EP2501689A1 Macrocyclic lactone derivatives for the treatment of cancer
09/26/2012EP2501686A1 Fluorinated oxa or thia heteroarylalkylsulfide derivatives for combating invertebrate pests
09/26/2012EP2501685A1 [1,5]-diazocin derivatives
09/26/2012EP2501683A1 Substituted carbamoylmethylamino acetic acid derivatives as novel nep inhibitors
09/26/2012EP2501679A1 Heterocyclic antiviral compounds
09/26/2012EP2501678A1 Aryl-pyridine derivatives as aldosterone synthase inhibitors
09/26/2012EP2501674A2 Processes for preparation of polymorphic forms of lacosamide
09/26/2012EP2501672A2 Compositions and methods for treating hyperproliferative disorders
09/26/2012EP2501669A2 Novel arylated camphenes, processes for their preparation and uses thereof
09/26/2012EP2501663A2 Method for production of f-18 labeled glutamic acid derivatives
09/26/2012EP2501416A1 Iodine-labeled homoglutamic acid and glutamic acid derivatives
09/26/2012EP2501410A2 Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
09/26/2012EP2501395A1 Par-1 antagonists for use in the treatment or prevention of influenza virus type a infections
09/26/2012EP2501392A1 Soluble physiological chitosan formulations combined with platelet-rich plasma (prp) for tissue repair
09/26/2012EP2501391A2 Pharmaceutical composition for the treatment of bladder disorders
09/26/2012EP2501390A2 Composition and methods for affecting cytokines and nf-kb
09/26/2012EP2501389A1 Polysaccharide / bmp complexes which are soluble at physiological ph
09/26/2012EP2501388A1 Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions
09/26/2012EP2501387A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
09/26/2012EP2501386A1 Quadruple therapy useful for treating persons afflicted with the human immunodeficiency virus (hiv)
09/26/2012EP2501385A1 Therapeutic combination comprising a cdc7 inhibitor and an antineoplastic agent
09/26/2012EP2501384A1 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
09/26/2012EP2501383A2 Oral formulation for dexlansoprazole
09/26/2012EP2501382A1 Apremilast for the treatment of sarcoidosis
09/26/2012EP2501381A2 Treatment of atrial fibrillation
09/26/2012EP2501380A2 Slow infusion of sulcardine and its salts
09/26/2012EP2501379A1 Combination
09/26/2012EP2501378A1 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
09/26/2012EP2501377A1 Novel schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (hiv)
09/26/2012EP2501376A2 Compositions for topical administration
09/26/2012EP2501375A1 Antimicrobial compositions containing free fatty acids
09/26/2012EP2501374A2 Coloring composition containing an aromatic compound and an initiator
09/26/2012EP2501373A1 Use of alpha 2 adrenergic receptor agonists for treating or preventing psoriasis
09/26/2012EP2501372A2 Intravenous infusion of curcumin and a calcium channel blocker
09/26/2012EP2501371A1 Use of hydroxytyrosol for improving muscle differentiation
09/26/2012EP2501370A1 Methods and compositions for treating solid tumors and other malignancies
09/26/2012EP2501369A1 Drug-loaded fibers
09/26/2012EP2501365A2 Capsules of active pharmaceutical ingredients and polyunsaturated fatty acid esters for the treatment of cardiovascular diseases
09/26/2012EP2501364A1 Parenteral formulations of gemcitabine derivatives
09/26/2012EP2501363A2 Inhalation solutions
09/26/2012EP2501236A1 Compounds and methods for kinase modulation, and indications therefor
09/26/2012EP2501234A1 Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine
09/26/2012EP2501233A1 Quinazoline compounds
09/26/2012EP2501232A1 Imidazole derivatives and methods of use thereof
09/26/2012EP2501231A1 Quinolizidinone carboxamide m1 receptor positive allosteric modulators
1 ... 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 ... 7860